Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Websites |
     
  3. Global Business Webistes |
     
  4. Contact Us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce font size Increase font size  
 
 

Financial Results

Contact us

Sanofi India Limited

54/A, Sir Mathuradas Vasanji Road,
Andheri East,
Mumbai 400 093
India

Board Tel.: (91-22) 28278000
Fax: (91-22) 28370939

Content :

Audited financial results for the year ended December 31, 2012

SANOFI INDIA LIMITED
Registered Office : 54/A, Sir Mathuradas Vasanji Road,
Andheri East, Mumbai 400 093

(Rs. Million)

ParticularsQuarter
ended 31.12.2012

(Unaudited)
Quarter
ended 30.09.2012

(Unaudited)
Quarter
ended 31.12.2011

(Unaudited)
Year
ended 31.12.2012

(Audited)
Year
ended 31.12.2011

(Audited)
1 Income from Operations
(a) Net Sales (net of excise duty)4,0073,9663,37914,93912,297
(b) Other Operating Income221191178792716
Total income from Operations (net)4,2284,1573,55715,73113,013
2 Expenditure
(a) Cost of Materials Consumed1,5251,3161,2935,5914,916
(b) Purchase of stock in trade4154394941,8531,353
(c) Changes in inventories of finished goods, work in progress and stock in trade77176(76)(89)(101)
(d) Employee benefits expense6094895032,1361,764
(e) Depreciation and amortisation expense223307142899311
(f) Other expenses8747417703,1222,604
(g) Total Expenses3,7233,4683,12613,51210,847
3 Profit from Operations before other income and finance costs (1-2)5056894312,2192,166
4 Other Income16175109412678
5 Profit before finance costs (3+4)6667645402,6312,844
6 Finance costs334144
7 Profit before tax and Exceptional items (5-6)6637615362,6172,840
8 Tax expense215248175850928
9 Net Profit for the period before Exceptional items (7-8)4485133611,7671,912
10 Exceptional item (net of tax)-----
11 Net Profit for the period after Exceptional items (9+10)4485133611,7671,912
12 Paid-up equity share capital (Face Value of Rs. 10 per share)230230230230230
13 Reserves excluding Revaluation Reserves as per balance sheet of previous accounting year11,66510,781
14 Earnings Per Share (EPS) before Exceptional items (Rs.) (Basic and diluted EPS for the period, for the year to date and for the previous year)19.4922.3015.7076.7183.01
15 Earnings Per Share (EPS) after Exceptional items (Rs.) (Basic and diluted EPS for the period, for the year to date and for the previous year)19.4922.3015.7076.7183.01

Part II

ParticularsQuarter ended 31.12.2012



(Unaudited)
Quarter ended 30.09.2012



(Unaudited)
Quarter ended 31.12.2011



(Unaudited)
Year ended 31.12.2012



(Audited)
Year ended 31.12.2011



(Audited)
A. PARTICULARS OF SHAREHOLDING
1 Public Shareholding
- Number of Shares9,121,0359,121,0359,121,0359,121,0359,121,035
- Percentage of Shareholding39.60%39.60%39.60%39.60%39.60%
2 Promoters and Promoter group Shareholding
a) Pledged/Encumbered
- Number of sharesNILNILNILNILNIL
- Percentage of shares (as a % of total shareholding of promoter and promoter group)NILNILNILNILNIL
- Percentage of shares (as a % of total share capital of the company)NILNILNILNILNIL
b) Non-encumbered
- Number of shares13,909,58713,909,58713,909,58713,909,58713,909,587
- Percentage of shares (as a % of total shareholding of promoter and promoter group)100.00%100.00%100.00%100.00%100.00%
- Percentage of shares (as a % of total share capital of the company)60.40%60.40%60.40%60.40%60.40%
Particulars3 Months ended December 31,2012
B. INVESTOR COMPLAINTS
Pending at the beginning of the quarterNIL
Received during the quarter29
Disposed of during the quarter29
Remaining unresolved at the end of the quarterNIL

The Statement of Assets and Liabilities as required under clause 41(V)(h) of the Listing Agreement is as under:

ParticularsAs at
December
31, 2012
Audited
As at
December
31, 2011
Audited
EQUITY AND LIABILITIES :
Shareholders' funds :
(a) Share capital230230
(b) Reserves & Surplus *11,81110,936
Sub-total - Shareholder's Funds12,04111,166
Non-current liabilities
(a) Other long term liabilities-10
(b) Long term provisions193196
(c) Deferred Tax Liabilities (Net)21384
Sub-total - Non-current liabilities406290
Current liabilities
(a) Trade Payables1,5421,476
(b) Other current liabilities850709
(c) Short-term provisions1,4751,384
Sub-total - Current liabilities3,8673,569
TOTAL EQUITY & LIABILITIES16,31415,025
ASSETS
Non-current assets
(a) Fixed Assets (Including Capital Work in Progress)7,4287,598
(b) Non current investments44
(c) Long term loans and advances582750
(d) Other non-current assets266
Sub-total - Non-current assets8,0408,358
Current assets
(a) Inventories2,7252,543
(b) Trade receivables9861,040
(c) Cash & Bank Balances4,2892,342
(d) Short term loans & advances233677
(e) Other current assets4165
Sub-total - Current assets8,2746,667
TOTAL ASSETS16,31415,025

* After considering Dividend

Notes:

  • The Accounts for the year ended December 31, 2012 were approved by the Board of Directors of the Company at its Meeting held on February 25, 2013.
  • The Board of Directors has recommended Final dividend of Rs.29 per Equity share of Rs.10 for the year ended December 31, 2012. An Interim dividend of Rs.4 per Equity share of Rs.10 had been paid in August 2012. The Interim and proposed Final Dividend will together amount to a distribution of Rs.760 million (excluding Dividend Distribution Tax) constituting 43% of the Company's Net Profit excluding Exceptional Items for the year ended December 31,2012.
  • During the quarter ended September 30, 2012, the Company changed its accounting policy with respect to amortisation of Goodwill. It was decided to amortise Goodwill on acquisition of business over a period of 10 years starting from the date of acquisition. In the past, Goodwill was not amortised but tested for impairment. As a result of this change, profit after tax for the quarter and year ended December 31, 2012 is lower by Rs.21 million and Rs 99 million respectively.
  • The profit for the year ended December 31, 2012 has been impacted due to the amortization costs relating to the Brands, Technical know-how and Goodwill acquired in 2011 from Universal Medicare Private Limited and lower interest income as a result of the above investment.
  • The Company has a single business segment namely "Pharmaceutical Business".
  • The figures for the previous periods have been re-grouped, wherever necessary.
  • The figures for the quarter ended December 31, 2012 are the balancing figures between audited figures in respect of the full financial year up to December 31, 2012 and the unaudited published year-to-date figures up to September 30, 2012, which was subject to limited review, being the date of the end of the third quarter of the said financial year.



SANOFI INDIA LIMITED


DR. SHAILESH AYYANGAR
MANAGING DIRECTOR

Updated February 25, 2013